CN Patent

CN102784386A — 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂

Assigned to Novo Nordisk AS · Expires 2012-11-21 · 13y expired

What this patent protects

本发明涉及含有肽和丙二醇的药物制剂，涉及制备该制剂的方法，以及涉及该制剂在治疗疾病和病症中的用途，为此该制剂中所含肽的用途得到表明。本发明进一步涉及减少肽制剂对注射装置的阻塞的方法和减少肽制剂生产过程中生产设备上沉积物的方法。

USPTO Abstract

本发明涉及含有肽和丙二醇的药物制剂，涉及制备该制剂的方法，以及涉及该制剂在治疗疾病和病症中的用途，为此该制剂中所含肽的用途得到表明。本发明进一步涉及减少肽制剂对注射装置的阻塞的方法和减少肽制剂生产过程中生产设备上沉积物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102784386A
Jurisdiction
CN
Classification
—
Expires
2012-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.